Overview


According to FutureWise analysis, the market for Animal Hormone Therapy is expected to grow at a CAGR of 5.70% over the forecast period of 2023-2031.

Animal hormone therapy, commonly referred to as hormone replacement therapy (HRT) for animals, is a specialized medical approach involving the precise administration of hormones to achieve specific physiological or therapeutic outcomes. Hormones, acting as intricate chemical messengers within an animal's complicated biological system, orchestrate a wide range of bodily functions encompassing growth, reproduction, metabolism, and beyond. This therapeutic strategy serves a multifaceted spectrum of objectives, encompassing the management of reproductive cycles in livestock to optimize breeding programs, modifying animal behaviour to reduce aggression or facilitate training, and treating various medical conditions such as hypothyroidism or diabetes in companion animals. Furthermore, hormone therapy finds relevance in both agricultural contexts for growth promotion and conservation initiatives aimed at safeguarding endangered species through controlled breeding and reintroduction programs. However, applying hormone therapy necessitates a comprehensive and meticulous approach guided by experienced veterinarians who navigate the complexities of dosages, timing, and administration methods. Crucially, the ethical considerations and welfare of the animals remain paramount, ensuring that the benefits of hormone therapy are achieved responsibly and with utmost care.

The animal hormone therapy market is a growing segment of veterinary medicine, driven by the need to manage animal reproductive cycles, behaviour, and medical conditions. This market encompasses livestock breeding, pet healthcare, and conservation efforts, with applications ranging from fertility enhancement to disease treatment. Advances in veterinary science and ethical considerations are shaping the development and responsible use of hormone therapies for various animal species.

FutureWise Market Research has published a report that provides an insightful analysis of Animal Hormone Therapy Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Animal Hormone Therapy Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Merck & Co. Inc.
  • Zoetis, Inc.
  • Elanco (Bayer Animal Health)
  • Boehringer Ingelheim
  • Bimeda Animal Health
  • Vetoquinol SA
  • Virbac Group
  • Ceva Sante Animale
  • Hipra Animal Health
  • Syntex SA
  • Huvepharma
  • Jurox Pty Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Animal Hormone Therapy Market:

  • September 2022 witnessed Merck Animal Health, also recognized as MSD Animal Health, revealing its formal commitment to procure Vence through a decisive agreement.
  • In March 2022, the Veterinary University Training and Research Center, situated in the Tripur District of Tamil Nadu, introduced an initiative aimed at diminishing the calving interval of Kangayam cows. 

The animal hormone therapy market is poised for growth, with several vital drivers propelling its expansion. Continuous advancements in research and technology offer opportunities to develop more targeted and effective animal hormone therapies, addressing specific health and productivity challenges. Additionally, regulatory agencies' increasing collaboration with industry players fosters a supportive environment, streamlining the approval process for new therapies and instilling stakeholder confidence. 

However, alongside these opportunities, certain restraints must be navigated. Ethical considerations surrounding the use of hormone therapies in animals can impact market acceptance, necessitating transparent communication and education initiatives to address concerns. Stringent regulatory frameworks, while offering guidance, can also create barriers to entry, requiring companies to demonstrate their products' safety and efficacy rigorously. Furthermore, the potential for unintended side effects or long-term consequences underscores the importance of comprehensive research and ongoing surveillance.

In conclusion, the animal hormone therapy market stands on the cusp of significant expansion, driven by technological innovation, regulatory support, and increasing consumer awareness. While ethical considerations and regulatory challenges may pose restraints, proactive measures such as education, rigorous research, and collaboration with regulatory bodies can mitigate these hurdles, ensuring the responsible and successful growth of the market

By Application

  • Growth Promotors
  • Performance Enhancers
  • Others

By Animals

  • Companion Animals
  • Livestock

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America stands out for its excellent animal healthcare infrastructure, encompassing countries such as Canada, the United States, and Mexico. This region is renowned for its robust research efforts in animal sciences and utilization of advanced technologies for animal product processing. As a result, North America is poised to maintain its market dominance in the foreseeable future. In a notable development in April 2022, the FDA sanctioned the usage of Bovine somatotrophin—an animal growth hormone—to enhance milk production in dairy cows. Government authorities are actively promoting the involvement of diverse stakeholders and the global adoption of hormone therapies, solidifying North America's position as a preferred market choice.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Animal Hormone Therapy Market By Application, By Animals, and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Hormone Therapy Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Hormone Therapy Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Hormone Therapy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Hormone Therapy Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Growth Promotors
        2. Performance Enhancers
        3. Others

  • 8.   Animal Hormone Therapy Market, By Animals Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companion Animals
        2. Livestock

  • 9.   North America Animal Hormone Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Animal Hormone Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Animal Hormone Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Animal Hormone Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Animal Hormone Therapy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Merck & Co. Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Zoetis, Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Elanco (Bayer Animal Health)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boehringer Ingelheim.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bimeda Animal Health
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Vetoquinol SA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Virbac Group
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ceva Sante Animale
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Hipra Animal Health
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Syntex SA
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Huvepharma
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Jurox Pty Ltd.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Compounded Bioidentical Hormone Therapy Market

Read More
Partner

Our Clients